September 3, 2019 – The U.S. Preventive Services Task Force released today a final recommendation statement on medication use to reduce risk of breast cancer. The Task Force found that some women at increased risk of breast cancer can benefit from risk-reducing medications. However, women who are not at increased risk should not take these medications. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the September 3, 2019 online issue of JAMA.
